Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 138 companies set new 52-week lows.
Chardan Capital Maintains Buy on Achilles Therapeutics, Lowers Price Target to $17
Chardan Capital analyst Geulah Livshits maintains Achilles Therapeutics (NASDAQ:ACHL) with a Buy and lowers the price target from $20 to $17.
Piper Sandler Maintains Overweight on Achilles Therapeutics, Lowers Price Target to $8
Piper Sandler analyst Joseph Catanzaro maintains Achilles Therapeutics (NASDAQ:ACHL) with a Overweight and lowers the price target from $10 to $8.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday
Gainers
AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.
Tesla, Coinbase Global And 41 Stocks Moving In Monday’s Mid-Day Session
Gainers
Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.
5 Value Stocks To Watch In The Healthcare Sector
What Defines a Value Stock?
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.